<p>Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens</p>Fangwen Zhang, Mingzhi Zhang, Xiaorui Fu et al.|Blood and Lymphatic Cancer Targets and Therapy|2019Cited by 11
Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective StudyLiangliang Ren, Mingzhi Zhang, Ling Li et al.|Indian Journal of Hematology and Blood Transfusion|2021Cited by 7